Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tiziana Life Sciences (US) (TLSA)
:TLSA
Holding TLSA?
Track your performance easily
TLSA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.41 - $1.74
Previous CloseN/A
Volume79.40K
Average Volume (3M)442.32K
Market Cap
$84.10M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.19
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 09, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding110,659,410
10 Day Avg. Volume403,604
30 Day Avg. Volume442,318
Standard Deviation0.38
R-Squared0.00921
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tiziana Life Sciences News
PremiumCompany Announcements
Tiziana’s Nasal Therapy Reduces GLP-1 Side Effects
PremiumCompany Announcements
Tiziana Life Sciences Expands MS Clinical Trial Network
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.28% Other Institutional Investors
99.52% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TLSA FAQ
What was Tiziana Life Sciences (US)’s price range in the past 12 months?
Tiziana Life Sciences (US) lowest stock price was $0.41 and its highest was $1.74 in the past 12 months.
What is Tiziana Life Sciences (US)’s market cap?
Tiziana Life Sciences (US)’s market cap is $84.10M.
When is Tiziana Life Sciences (US)’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tiziana Life Sciences (US)’s earnings last quarter?
Currently, no data Available
Is Tiziana Life Sciences (US) overvalued?
According to Wall Street analysts Tiziana Life Sciences (US)’s price is currently Overvalued.
Does Tiziana Life Sciences (US) pay dividends?
Tiziana Life Sciences (US) pays a Notavailable dividend of $0.029 which represents an annual dividend yield of N/A. See more information on Tiziana Life Sciences (US) dividends here
What is Tiziana Life Sciences (US)’s EPS estimate?
Tiziana Life Sciences (US)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tiziana Life Sciences (US) have?
Tiziana Life Sciences (US) has 110,659,410 shares outstanding.
What happened to Tiziana Life Sciences (US)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tiziana Life Sciences (US)?
Currently, no hedge funds are holding shares in TLSA
---
Tiziana Life Sciences Stock Smart Score
Company Description
Tiziana Life Sciences (US)
Tiziana Life Sciences Plc is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.
---
Technical Analysis
Medicinova
―
vTv Therapeutics
―
Ovid Therapeutics
―
Oramed Pharm
―
Kodiak Sciences
―
Adverum Biotechnologies
―
---